FURIEX PHARMACEUTICALS INC's ticker is FURX and the CUSIP is 36106P101. A total of 5 filers reported holding FURIEX PHARMACEUTICALS INC in Q1 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2014 | $2,689,000 | -40.5% | 25,326 | -51.2% | 0.06% | +18.5% |
Q1 2014 | $4,518,000 | +105.6% | 51,938 | -0.7% | 0.05% | +107.7% |
Q4 2013 | $2,198,000 | +90.0% | 52,330 | +99.0% | 0.03% | -10.3% |
Q3 2013 | $1,157,000 | +29.3% | 26,298 | +0.1% | 0.03% | +20.8% |
Q2 2013 | $895,000 | -9.2% | 26,269 | -0.1% | 0.02% | -7.7% |
Q1 2013 | $986,000 | – | 26,294 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 319,536 | $13,424,000 | 9.48% |
Global Alpha Capital Management Ltd. | 67,120 | $2,996,000 | 4.61% |
Consonance Capital Management LP | 648,829 | $27,257,000 | 4.47% |
Alistair Capital Management, L.L.C. | 168,738 | $7,089,000 | 3.18% |
Artal Group S.A. | 870,842 | $36,584,000 | 1.31% |
Breithorn Capital Management | 48,058 | $2,019,000 | 1.13% |
THOMPSON SIEGEL & WALMSLEY LLC | 600,615 | $25,232,000 | 0.59% |
FRANKLIN STREET ADVISORS INC /NC | 52,325 | $2,198,000 | 0.44% |
Visium Asset Management, LP | 312,698 | $13,136,000 | 0.26% |
AMERICAN CAPITAL MANAGEMENT INC | 49,134 | $2,064,000 | 0.26% |